[go: up one dir, main page]

NO20032328L - protease inhibitors - Google Patents

protease inhibitors

Info

Publication number
NO20032328L
NO20032328L NO20032328A NO20032328A NO20032328L NO 20032328 L NO20032328 L NO 20032328L NO 20032328 A NO20032328 A NO 20032328A NO 20032328 A NO20032328 A NO 20032328A NO 20032328 L NO20032328 L NO 20032328L
Authority
NO
Norway
Prior art keywords
protease inhibitors
protease
inhibitors
Prior art date
Application number
NO20032328A
Other languages
Norwegian (no)
Other versions
NO20032328D0 (en
Inventor
Daniel F Veber
Robert W Marquis
Dennis Shinji Yamashita
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20032328D0 publication Critical patent/NO20032328D0/en
Publication of NO20032328L publication Critical patent/NO20032328L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20032328A 2000-11-22 2003-05-22 protease inhibitors NO20032328L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25250800P 2000-11-22 2000-11-22
PCT/US2001/051647 WO2003053331A2 (en) 2000-11-22 2001-11-19 Protease inhibitors

Publications (2)

Publication Number Publication Date
NO20032328D0 NO20032328D0 (en) 2003-05-22
NO20032328L true NO20032328L (en) 2003-07-02

Family

ID=22956303

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032328A NO20032328L (en) 2000-11-22 2003-05-22 protease inhibitors

Country Status (17)

Country Link
EP (1) EP1392657A4 (en)
JP (1) JP2005513083A (en)
KR (1) KR20040004445A (en)
CN (1) CN1635903A (en)
AR (1) AR034278A1 (en)
AU (1) AU2001298052A1 (en)
BR (1) BR0115473A (en)
CA (1) CA2436850A1 (en)
CZ (1) CZ20031403A3 (en)
HU (1) HUP0301964A3 (en)
IL (1) IL155997A0 (en)
MX (1) MXPA03004542A (en)
NO (1) NO20032328L (en)
PL (1) PL366232A1 (en)
UY (1) UY27032A1 (en)
WO (1) WO2003053331A2 (en)
ZA (1) ZA200303848B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
NZ520588A (en) 2000-03-21 2004-06-25 Smithkline Beecham Corp Protease inhibitors
AP2002002671A0 (en) * 2000-06-14 2002-12-31 Smithkline Beecham Corp Protease inhibitors.
US20110092484A1 (en) 2007-06-08 2011-04-21 Nippon Chemiphar Co., Ltd. Therapeutic or prophylactic agent for cerebral aneurysm
EP2216047A4 (en) 2007-10-24 2011-12-28 Nat Univ Corp Tokyo Med & Dent REGULATOR FOR SIGNALING THE TOLL LIKE RECEPTOR WITH A CATHEPSIN INHIBITOR AS AN ACTIVE SUBSTANCE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1043536A1 (en) * 1998-12-23 2002-09-20 Smithkline Beecham Corporation Protease inhibitors
NZ520588A (en) * 2000-03-21 2004-06-25 Smithkline Beecham Corp Protease inhibitors
AP2002002671A0 (en) * 2000-06-14 2002-12-31 Smithkline Beecham Corp Protease inhibitors.

Also Published As

Publication number Publication date
UY27032A1 (en) 2002-07-31
WO2003053331A3 (en) 2003-11-13
MXPA03004542A (en) 2003-09-10
IL155997A0 (en) 2003-12-23
NO20032328D0 (en) 2003-05-22
ZA200303848B (en) 2004-06-28
CA2436850A1 (en) 2003-07-03
PL366232A1 (en) 2005-01-24
BR0115473A (en) 2004-09-28
AR034278A1 (en) 2004-02-18
CN1635903A (en) 2005-07-06
JP2005513083A (en) 2005-05-12
AU2001298052A1 (en) 2003-07-09
HUP0301964A3 (en) 2007-09-28
CZ20031403A3 (en) 2003-10-15
EP1392657A4 (en) 2004-03-10
KR20040004445A (en) 2004-01-13
EP1392657A2 (en) 2004-03-03
HUP0301964A2 (en) 2007-02-28
WO2003053331A2 (en) 2003-07-03

Similar Documents

Publication Publication Date Title
CY2012007I1 (en) PEPTIDEMIMETIC PROTEASE INHIBITORS
NO20012980D0 (en) protease inhibitors
EP1272467A4 (en) Cathepsin cysteine PROTEASE INHIBITORS
ATE333454T1 (en) METALLOPROTEINASE INHIBITORS
EE200300439A (en) Metalloproteinase inhibitors
DE60002193D1 (en) METALOPROTEASE INHIBITORS
AU4344101A (en) Protease inhibitors
ATE534622T1 (en) ASPARTYL PROTEASE INHIBITORS
EE200300450A (en) Metalloproteinase inhibitors
DK1272488T3 (en) Tri-aryl-substituted ethane-PDE4 inhibitors
NO20014243D0 (en) Dihetero-substituted metalloprotease inhibitors
NO20025786D0 (en) protease inhibitors
NO20025005L (en) protease inhibitors
NO20032328L (en) protease inhibitors